Interventional pain management involves minimally invasive procedures like epidural injections, facet joint injections, sympathetic nerve blocks and rhizotomy for effective pain relief without major surgery. These procedures use imaging and guidance techniques along with local anaesthesia to accurately identify the source of pain and treat it. They provide faster recovery and have lesser complications compared to complex spinal surgeries. The rising prevalence of chronic pain disorders like lower back pain, arthritis and neurological conditions is driving the demand for interventional pain management.
The global Interventional Pain Management Market is estimated to be valued at US$ 7.49 Bn in 2023 and is expected to exhibit a CAGR of 25% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of minimally invasive procedures is one of the major trends in the interventional pain management market. Minimally invasive techniques like robotic assisted surgery, laser therapy and image guided spinal procedures offer improved accuracy, reduced risk of infections and blood loss, smaller incisions and scars, shorter hospital stay and faster recovery compared to open surgeries. Advanced visualization systems and navigation tools help interventional physicians to precisely identify the source of pain and safely and effectively treat it. This has boosted the demand for interventional pain management and driven the market growth over the recent years.
Segment Analysis
The global interventional pain management market is segmented based on product, application, end user and geography. By product, analgesic implants dominates the market and is expected to remain high growth segment during the forecast period. Analgesic implants offer longer relief from chronic pain with minimally invasive procedures having advantages over alternative therapies.
Key Takeaways
The Global Interventional Pain Management Market Size is expected to witness high growth during the forecast period of 2023 to 2030. The global Interventional Pain Management Market is estimated to be valued at US$ 7.49 Bn in 2023 and is expected to exhibit a CAGR of 25% over the forecast period 2023 to 2030.
North America remains the largest as well as the fastest growing regional market for interventional pain management. The growth in the region can be attributed to the growing prevalence of chronic pain and rising geriatric population. In addition, favorable reimbursement policies and presence of key players in the region also supports the market growth.
Key players: Key players operating in the interventional pain management market are Medtronic, Abbott, Stryker, B. Braun Melsungen AG, Boston Scientific Corp., Baxter, OMRON Healthcare, Inc. Medtronic dominates the global market with wide product portfolio and strong geographical presence across major markets.
Get more insights on this topic:
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast period On the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast period On the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast periodOn the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast periodOn the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
